TOKYO, Jun 19 (Pulse News Wire) – Genova,Inc. (9341.T) entered an improvement period as of March 31, 2026, due to non-compliance with listing standards on the Tokyo Stock Exchange Prime Market.
The company's stock market capitalization did not meet the criteria, leading to potential risks of being designated as a surveillance subject by October 2027 if improvements are not made within the specified timeframe. To address this issue, Genova outlined several strategies aimed at enhancing its stock price and overall market performance. Key initiatives include boosting sales through the MedicalDOC internet media platform, expanding its dental distribution business, maintaining stable shareholder returns, and intensifying investor relations activities.
Specifically, the company projects a significant increase in segment revenue for the medical platform division and expects substantial cost optimization and top-line growth in the dental distribution sector. Genova also noted that while it remains in an investment phase, it will continue to implement consistent shareholder return policies, planning to distribute a dividend per share of March 31, 2026 for the fiscal year ending March 31, 2027, with a payout ratio of March 31, 2027. The company emphasized that achieving compliance with listing standards is a crucial part of its strategic priorities and will actively pursue necessary measures to ensure continued listing status.
🟡 Confidence: Standard AI-translated content.